Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report (2013)
- Authors:
- USP affiliated authors: CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; QUEIROZ, REGINA HELENA COSTA - FCFRP ; CHAGAS, MARCOS HORTES NISIHARA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP
- Unidades: FMRP; FCFRP
- DOI: 10.1111/jcpt.12018
- Subjects: CANNABIS (APLICAÇÕES TERAPÊUTICAS;EFEITOS ADVERSOS); TRANSTORNOS RELACIONADOS AO USO DE SUBSTÂNCIAS
- Language: Inglês
- Imprenta:
- Publisher place: Chichester
- Date published: 2013
- Source:
- Título do periódico: Journal of Clinical Pharmacy and Therapeutics
- ISSN: 0269-4727
- Volume/Número/Paginação/Ano: v. 38, n. 2, p. 162-164, 2013
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
-
ABNT
CRIPPA, José Alexandre de Souza et al. Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report. Journal of Clinical Pharmacy and Therapeutics, v. 38, n. 2, p. 162-164, 2013Tradução . . Disponível em: https://doi.org/10.1111/jcpt.12018. Acesso em: 19 abr. 2024. -
APA
Crippa, J. A. de S., Hallak, J. E. C., Machado-de-Sousa, J. P., Queiroz, R. H. C., Bergamaschi, M., Chagas, M. H. N., & Zuardi, A. W. (2013). Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report. Journal of Clinical Pharmacy and Therapeutics, 38( 2), 162-164. doi:10.1111/jcpt.12018 -
NLM
Crippa JA de S, Hallak JEC, Machado-de-Sousa JP, Queiroz RHC, Bergamaschi M, Chagas MHN, Zuardi AW. Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2013 ; 38( 2): 162-164.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1111/jcpt.12018 -
Vancouver
Crippa JA de S, Hallak JEC, Machado-de-Sousa JP, Queiroz RHC, Bergamaschi M, Chagas MHN, Zuardi AW. Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2013 ; 38( 2): 162-164.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1111/jcpt.12018 - Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain
- Pharmacological interventions in the treatment of acute affects of cannabis: a systematic review of literature
- Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats
- Rimonabant effects on anxiety induced by simulated public speaking in health humans: a preliminary report
- Cannabidiol (CBD) for the treatment of bipolar affective disorder
- Oxytocin does not improve performance of patients with schizophrenia and healthy volunteers in a facial emotion matching task
- Structural and functional neuroimaging findings associated with the use of clozapine in schizophrenia: a systematic review
- Neuroimaging correlates of pharmacological and psychological treatments for specific phobia
- Safety and side effects of cannabidiol, a Cannabis sativa constituent
- Neuroimaging in specific phobia disorder: a systematic review of the literature
Informações sobre o DOI: 10.1111/jcpt.12018 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
